SCHEMBL4467543

SCHEMBL4467543

CC1=Cc2c(cccc2-c2cccc3ccccc23)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.41
HTR1A P08908 2/20 0.41
ALDH1A1 P00352 2/20 0.39
CYP2A6 P11509 1/20 0.39
DHFR P00374 1/20 0.37
PTPN1 P18031 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
SLC6A3 Q01959 1/20 0.35
HPGD P15428 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30229790 1.00 HTR7 (0.41) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL7651334 0.92 HPRT1 (0.44) HTR7HTR1AALDH1A1CYP2A6HPGD
SCHEMBL22685830 0.85 ALDH1A1 (0.42) HTR7HTR1AALDH1A1CYP2A6MAOA
SCHEMBL6330045 0.85 HTR1A (0.34) HTR7HTR1AALDH1A1CYP2A6KDM4E
SCHEMBL690405 0.83 ALDH1A1 (0.41) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL2964779 0.83 HTR7 (0.35) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL29776114 0.82 HTR1A (0.45) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL29060477 0.82 HTR1A (0.45) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL5603061 0.82 DHFR (0.35) HTR7HTR1AALDH1A1CYP2A6DHFR
SCHEMBL2969288 0.82 KDM4E (0.35) HTR7HTR1AALDH1A1CYP2A6DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38683-E1 Preparation of titanocenes BOULDER SCIENTIFIC COMPANY (US) 2005-01-04 US claimed
EP-0883623-B1 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENT CO (US) 2003-03-05 EP claimed
US-6262197-B1 AS POLYMERIZATION CATALYST IN OLEFIN POLYMERIZATION TARGOR GMBH (DE) 2001-07-17 US claimed
EP-0883623-A4 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENT CO (US) 2000-06-28 EP claimed
EP-0883623-A1 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENTIFIC COMPANY (US) 1998-12-16 EP claimed
US-5847176-A Preparation of chiral titanocenes BOULDER SCIENTIFIC COMPANY (US) 1998-12-08 US claimed
WO-1998022477-A1 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENTIFIC COMPANY (US) 1998-05-28 WO claimed
US-5670681-A Process for preparing a carbon-bridged biscyclopentadiene compound HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-23 US claimed
EP-4635992-A1 POLYETHYLENE AND FILM COMPRISING SAME LG Chem, Ltd. (KR) 2025-10-22 EP disclosed
US-20250320321-A1 Polyethylene and Film Comprising the Same LG CHEM, LTD. (KR) 2025-10-16 US disclosed
US-12358938-B2 Transition metal compound and method of preparing polypropylene using the same LG CHEM, LTD. (KR) 2025-07-15 US disclosed
US-20250144607-A1 Hybrid Metallocene Catalyst and Method for Preparing Polyethylene Using the Same LG CHEM, LTD. (KR) 2025-05-08 US disclosed
CN-119654354-A Polyethylene and film containing the same 株式会社LG化学 2025-03-18 CN disclosed
EP-3725816-B1 ETHYLENE-BASED POLYMER HAVING EXCELLENT LONG-TERM PRESSURE RESISTANCE CHARACTERISTICS, AND PIPE USING SAME HANWHA SOLUTIONS CORP (KR) 2025-03-05 EP disclosed
US-5532396-A HAS TWO INDENYL LIGANDS WITH DIFFERENT SUBSTITUTION PATTERNS ON THE SIX-MEMBERED RINGS. LIGANDS ARE JOINED BY DIVALENT GROUP CONNECTING FIVE-MEMBERED RINGS. METAL IS FROM GROUP /IVB/, /VB/ OR /VIB/. OLEFIN POLYMERIZATION CATALYST HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-02 US disclosed
EP-0704454-A2 Process for the preparation of a bridged metallocene HOECHST AKTIENGESELLSCHAFT (DE) 1996-04-03 EP disclosed
CN-1107854-A Metalocenes compound HOECHST AG (DE) 1995-09-06 CN disclosed
EP-0659757-A1 Metallocenes HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-28 EP disclosed
US-5360921-A REACTING LITHIUM, SODIUM OR POTASSIUM SALT OF A CYCLOPENTADIENE DERIVATIVE WITH A SILICON OR GERMANIUM HALIDE COMPOUND IN THE PRESENCE OF A CYANIDE OR A THIOCYANATE MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-11-01 US disclosed
EP-0617044-A2 Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358938-B2 Transition metal compound and method of preparing polypropylene using the same PMS2, MUS81, PMM2 HTR7 4026/4885HTR1A 1923/4885ALDH1A1 2223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.